Please login to the form below
chronic pain
This page shows the latest chronic pain news and features for those working in and with pharma, biotech and healthcare.
FDA awards another non-opioid pain drug breakthrough status
FDA awards another non-opioid pain drug breakthrough status. Second drug fast-tracked amid addiction epidemic. ... Studies suggest that that one in 10 patients in the US become addicted or dependent on opioids following surgery, adding to their
Latest news
-
Regeneron and Teva close gap on rivals with NGF pain drug
therapeutic choices to treat their chronic pain, other than with non-steroidal anti-inflammatory drugs or opioids," said Yancopolous. ... In contrast to opioids, which alter pain perception by targeting opioid receptors, NGF inhibitors block signalling
-
AbbVie’s blockbuster-in-waiting for endometriosis gets FDA nod
In trials, it significantly reduced daily menstrual pelvic pain, non-menstrual pelvic pain, and pain associated with sex. ... Endometriosis is often characterised by chronic pelvic pain that can impact women's daily activities, ”said Hugh Taylor of
-
Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
The 16-week study in patients with osteoarthritis (OA) pain evaluated subcutaneous administration of tanezumab, one of a new class of nerve growth factor (NGF) inhibitor drugs. ... In addition to OA pain, the biologic is being evaluated for chronic low
-
Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
The 16-week study in patients with osteoarthritis (OA) pain evaluated subcutaneous administration of tanezumab, one of a new class of nerve growth factor (NGF) inhibitor drugs. ... In addition to OA pain, the biologic is being evaluated for chronic low
-
Europe's public-private alliance targets pain management
A key aim of the 23m scheme is to try to find alternatives to opioid analgesics for chronic pain – which have significant problems including side effects and the risk of addiction – ... and to identify ways to improve the care of people suffering
More from news
Approximately 2 fully matching, plus 92 partially matching documents found.
Latest Intelligence
-
Tools for the digital world
HealthUnlocked (HU) is one such network, designed to provide patients with a space in which they can discuss symptoms, relief and ways of coping with day-to-day chronic pain.
-
Pursuing better outcomes for people with pain
Pain is a sensation that we have all experienced in one form or another, but chronic pain that limits what people can do each day is unfortunately a reality for millions ... for chronic pain conditions.”.
-
Grünenthal's relentless pursuit of relief
The pursuit of pain relief is nowhere near over and many companies and institutions are chasing answers to reduce the impact of chronic pain and its corrosive byproducts: anxiety, fatigue, depression ... With one in five European adults affected by
-
Deal Watch January 2016
Focusing on development for chronic pain, Quartet will receive a $20m fee (representing the upfront and milestones) to cover development through to phase IIa. ... 150. MannKind/ Receptor Life Sciences. Licence, collaboration. Multiple inhaled therapeutic
-
Oral biologics delivery still elusive
At the moment, biologics are generally delivered by intravenous or subcutaneous injection, which is effective but not desirable for patients, particularly for chronic conditions. ... Cara Therapeutics has a chronic pain treatment based on a peptide that
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Portland Health adds to staff as business grows
Meanwhile, Russell, who joins Portland Health after more than three years with Insight, is a parliamentary, public affairs and campaigns specialist, with experience in endocrinology, oncology, chronic pain, haematology and sexual
-
Bray Leino opens health and wellbeing PR practice
Diagnostics; and chronic pain for Pfizer.
-
Zogenix appoints Pfizer’s R Scott Shively as chief commercial officer
Pain specialist Zogenix has appointed former Pfizer VP R Scott Shively as its new chief commercial officer. ... for the treatment of chronic pain. “
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Research Partnership has published a new Living with Chronic Pain market report for 2016
Research Partnership has published a new Living with Chronic Pain market report for 2016. ... Chronic pain is defined as pain lasting longer than 6 months and affects 100 million Americans.
-
Research Partnership
Prescription medicines. Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases. ... 260 million people from mainland China now suffer from a chronic disease
More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
-
Sudler London - Account Director
-
Competitive
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Senior Medical Writer
-
Salary is DOE
-
Systematic Review Lead- London
-
Negotiable
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Sudler London - Senior Medical Writer
-
Competitive
- Account Director or Senior Account Director
-
Salary TBC
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Account Manager
-
Negotiable
Subscribe to our email news alerts
- Moving annual total (MAT)
- Key success factor (KSF)
- AZ prepares to file COPD triple, taking on rival GSK
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Gilead targets hep B in half a billion dollar deal with Precision BioSciences
- Teva wins FDA OK for crucial migraine drug
- IPA’s new training course, Silver Buck launched and ARK moves office
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- The critical role of science in healthcare communications
- UK pharma to work with innovation network on NHS uptake
- Bayer roll-out of haemophilia drug Jivi gathers pace
PMHub
PharmiWeb Solutions
PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
